RxDoctor Payments Data

Jeremy Walters, DPM

Podiatrist · Suffolk, VANPI 1831450436

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $47,140 of the $59,989 with a category attached, or 78.6%. 36 manufacturers reported payments, led by International Life Sciences at 24.9% of the total. 2025 is the largest year on record at $21,173, more than ten times the $1,312 reported in 2019. Among podiatrist clinicians in VA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$59,989in general payments, 2019–2025

Across 220 payments — averaging $272.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • International Life Sciences$15K
  • Trimed, Inc.$8K
  • Forma Medical$6K
  • Johnson & Johnson$6K
  • Treace Medical Concepts, Inc.$5K
  • Crossroads Extremity Systems, LLC$5K
  • plus $16K from 30 others

What the payments were for

  • Consulting fees$47,14079%
  • Speaking & faculty fees$1,5003%
  • Travel & lodging$3,4136%
  • Food & beverage$7,93613%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$59,989 in reported general payments places this provider in the 95th percentile of 126 podiatrist providers in Virginia.

See all podiatrist providers in Virginia

Medicare billing

Part B allowed, 2024
$741,818
Medicare patients
489
Services billed
2,680

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Methylprednisolone86$669
Ibuprofen33$233
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen23$167
Clindamycin Hcl19$162
Cephalexin34$159

Paid to pharmacies, not to this prescriber.

Other podiatrist in Suffolk

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →